2BB score and signals
Cadrenal Therapeutics, Inc.’s current 2BB score is 16 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 2 | Very Low |
| Momentum | 51 | Stable |
| Financial strength | 33 | Weak |
| Quality | 20 | Weak |
| Risk | 91 | Very High |
Cadrenal Therapeutics, Inc. (CVKD) Stock Score & Signals
Cadrenal Therapeutics, Inc. (CVKD) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 16 out of 100.
Company facts
| Founded | 2022 |
| Employees | 5 |
| 52-week range | $0.82 – $14.35 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-03-29 | — | -0.8772 | — | $0.00 |
| 2026-11-09 | — | -0.9316 | — | $0.00 |
| 2026-08-10 | — | -1.4484 | — | $0.00 |
| 2026-05-07 | -1.04 | -1.6524 | $0.00 | $0.00 |